Established in 2004, ConvenePro is a privately held small business specializing in the delivery of highly regulated and innovative programming in the life sciences. We partner with public and private clients, including Fortune 500 companies, to plan and execute results-proven and industry compliant programs to leverage their message.We oversee end-to-end program logistics using specially designed proprietary processes and methods. Our depth and breadth of knowledge of federally mandated compliance, long history of providing superior customer service and effective and timely communication…
Creabilis is a clinical-stage, specialty pharmaceutical company focusing on the development of innovative, first-in-class topical treatments in the field of dermatology. The Company’s lead product, CT327, is a Phase III-ready topical treatment for chronic pruritus (itch), which the Company believes is the most advanced, novel, topical treatment in development for the indication. Pruritus is a debilitating symptom of many dermatological diseases, with a significant negative impact on a patient’s quality of life.
ProNAi Therapeutics is a drug development company advancing targeted therapeutics for the treatment of patients with cancer. We are an ambitious oncology drug development company oriented towards registration and commercialization. We have a world-class management team with a proven track record of success in oncology drug development and we intend to build a broad and diverse pipeline of promising oncology assets against emerging targets on the leading edge of cancer biology.
Applied Minerals is the leading producer of halloysite clay and advanced natural iron oxide solutions from its wholly-owned Dragon Mine property in Utah. Halloysite is aluminosilicate clay that forms naturally occurring nanotubes. In addition to serving the traditional halloysite markets for use in technical ceramics and catalytic applications, the Company has developed niche applications that benefit from the tubular morphology of its halloysite. These applications include carriers of active ingredients in paints,coatings and building materials, environmental remediation,agricultural…
Auritec Pharmaceuticals, Inc. is a research and development (R&D) company, specializing in innovative, extended release drug delivery systems. Auritec was founded by Thomas J. Smith, MD. Dr. Smith was previously Medical Director and Chairman at Control Delivery Systems, Inc. (CDS), where he was the co-founder and PI on key patents. CDS, now Psivida Inc. (NASDQ - PSDV), is a successful device company specializing in ophthalmic extended release therapies. Dr. Smith is joined on Auritec's management team by Gary Ransom, a seasoned international business executive, who focuses on strategy,…
Marsala Biotech Inc. is an Oncology company developing new treatments for cancer. The Company's lead technology E10A, is being evaluated in head and neck cancer patients. Currently there are only 2 FDA approved drugs which have significant drawbacks. Phase III clinical trials of E10A are planned for 2013 in China and North America. In addition to a huge commercial potential, E10A would help address this significant unmet medical need.Marsala's lead product E10A has established potential to treat Head and Neck Cancer, which has a market potential of 3.2 billion USD. E10A also has synergistic…
Alexion is a global biopharmaceutical company focused on developing and delivering life-transforming therapies for patients with severe and life-threatening rare diseases. Patients with these devastating diseases often have no effective treatment options, and they and their families suffer with little hope. Our goal is to deliver medical breakthroughs where none currently exist. We are driven because we know people's lives depend on our work.Our first commercial product is Soliris® (eculizumab), the world's first and only approved terminal complement inhibitor. Today, Soliris is approved in…
The biggest unmet medical need is to provide safe and efficacious drugs to the patient. However, the pharmaceutical industry is currently facing a litany of challenges, including but not limited to: 1) lead identification; 2) lead optimization & prioritization; 3) predicting side effects and toxicity; 4) meeting efficacy requirements; 5) maximizing patent life on the market; and 6) product rescue/repositioning. As a result, R&D success rates are falling, and R&D spending is not contributing to increased sales. According to research by Jack Scannell published in Nature, “...the number of new…
Cubist Pharmaceuticalsis a bio-pharmaceutical company focused on the research, commercialization and creation of pharmaceutical products that address unmet medical needs in the acute care environment.
About LubrizolLubrizol may not be a household name, but chances are good that you'll find Lubrizol products throughout your home…your workplace…anywhere your day takes you. As a company, we strive to be an essential ingredient in our customer's success through collaboration, applied science and demonstrated value. By formulating complex chemicals at the molecular level, Lubrizol engineers and chemists develop additives, ingredients and compounds that amplify the quality and performance of other products while reducing their environmental impact. And those products cover a wide range of…
QUADRAS is a global provider of unique, enterprise-class Data Collection and Professional Service solutions, with a specialization in mobile data capture and RFID technologies. Our business solutions are focused on optimizing operations, reducing expenses, and improving business processes, and they have successfully been applied across a wide range of industries.As recognized leaders in the Data Collection, RFID, and EAM/IT Consulting fields, we stand behind our know-how, our recommendations, and our implementations - we will execute what we promise and help you attain your key performance…
One Liner Description: Kona Deep® - The ONLY all natural electrolyte water on this planet! Bottled at the source in Hawaii.Business Summary: We manufacture and bottle "Kona Deep®", a deep seawaterdrinking brand. Deep seawater has become the No.1 food export of Hawaii, havingsurpassed Macadamia Nuts and Coffee (combined) in 2007. In 2011, over $140,000,000in deep sea bottled drinking water was exported from the State of Hawaii. In 2012, KonaDeep® became the #1 top-selling deep seawater brand in the USA. Our plan is tobecome #1 in the global market by leveraging our status as the #1 brand in…
At Camargo Pharmaceutical Services, we are strategic thinkers and doers. Camargo is your full-service drug development partner specializing in the 505(b)(2) process — a holistic approach for developing products that offer differentiated benefits. Before development even begins, we help verify profit potential by working with your team to develop a comprehensive program and timeline complete with critical milestones and cost objectives. We manage every facet of the plan throughout your development continuum, from feasibility assessments, formulation and testing the drug product, to…
Natural Vitamins Laboratories is an industry leading manufacturer of health and wellness care solutions. Our products include a comprehensive line of nutritional supplements, multi-vitamins, minerals, herbs Established in 1993, Natural Vitamins Laboratories is committed to provide you with the lifelong benefits of sound nutrition and wellness practices.
U-M Tech Transfer is the University organization responsible for the transfer of University technology to the marketplace.Mission:To effectively transfer University technologies to the market so as to generate benefits for the University, the community and the general public.
Neurotez, Inc. is a private corporation whose primary goal is to develop a Leptin product as a novel hormone replacement therapy for Alzheimer's disease (AD) and/or as a preventative for those who are at risk.Leptin, a naturally occurring human hormone associated with various metabolic effects, has a large number of receptors in memory centers of the brain. This protein is often present at decreased levels in patients suffering from Alzheimer's disease, and cognitive deterioration in AD patients correlates strongly with a decline in circulating Leptin levels. The administration of Leptin…
Alpha Cancer Technologies Inc., (ACT) is a private clinical stage biotechnology company with products under development in oncology and auto-immune disease indications. The company’s drug products use our proprietary recombinant human alpha fetoprotein (AFP) with unique immuno-oncology properties.One of the largest US biotech companies recently purchased a 14% equity stake in ACT for US $7.5 million as part of a larger financing with institutional and private investors.
Our primary strategy is comprised of acquiring, developing and commercializing a broad and diverse pipeline of late-stage clinical and commercial products. In addition to building an efficient in-house clinical development organization with regulatory and data management capabilities, Spectrum has established a commercial infrastructure for itsmarketed products. We have two oncology products on the market, one for low-grade or follicular non-Hodgkin's lymphoma and one for advanced metastatic colorectal cancer, as well as two drugs in late stage development: apaziquone and belinostat, along…
ABOUT MEDICUREMedicure is a specialty pharmaceutical company engaged in the research, clinical development and commercialization of human therapeutics.Medicure's core focus is on the US commercial sales of its FDA approved small molecule, AGGRASTAT. Acquired in 2006, AGGRASTAT is experiencing renewed interest from hospitals and clinicians in the US due to its compelling clinical and economic evidence. The Company has an experienced commercial team dedicated exclusively to the marketing of AGGRASTAT.AGGRASTAT, in combination with heparin, is indicated for the treatment of acute coronary…
About UsVisionSynageva BioPharma is a clinical stage biopharmaceutical company dedicated to discovering, developing and delivering medicines for patients with rare disease and unmet medical need. At Synageva, we share a passion and commitment to improving the lives of patients with rare diseases. Our team is drawn from leading biotech companies and has helped bring several life-saving therapies to patients whose diseases were once considered too rare for developing treatments. We believe that every patient deserves treatment options, regardless of the rarity of their disease.ProgramsOur lead…
